You appear to be offline. Some data may be unavailable until your connection is restored.

PODD

Stock

Insulet Corporation

Create price alert
$149.29
-$0.74 (0.49%)
At close: Nov 12, 2026, 4:00 PM

Description

Insulet Corporation designs, manufactures and markets the Omnipod platform, a tubeless, wearable insulin‑delivery system that includes disposable Pods, wireless controllers and integrated diabetes‑management software. The company operates in the medical‑device segment of the healthcare sector, focusing on diabetes management technology and related drug‑delivery applications. Insulet is a leading provider of tubeless insulin pumps, distinguished by its Omnipod 5 automated insulin‑delivery system and a growing presence in the United States and international markets, competing with other major diabetes‑device manufacturers such as Medtronic and Tandem.

Quarterly Earnings

QuarterDateEPS
Q4 FY26Feb 3, 2027 (est.)—
Q3 FY26Nov 4, 2026$1.99
Q2 FY26Aug 5, 2026$1.66
Q1 FY26May 6, 2026$1.42
Q4 FY25Feb 18, 2026$1.55

Stay ahead of PODD earnings

Get reminders ahead of PODD's next earnings report, so you always know when results are coming.

Other Healthcare stocks in the S&P 500